𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Invited Review Recognition and management of angiotensin converting enzyme inhibitor fetopathy

✍ Scribed by Aileen B. Sedman; David B. Kershaw; Timothy E. Bunchman

Publisher
Springer
Year
1995
Tongue
English
Weight
412 KB
Volume
9
Category
Article
ISSN
0931-041X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of angiotensin-converting enz
Management of angiotensin-converting enzyme inhibitor–induced angioedema
✍ Samer Al-Khudari; Michael J. Loochtan; Edward Peterson; Kathleen L. Yaremchuk 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

## Abstract ## Objectives/Hypothesis: To develop and validate a clinical algorithm for management of patients with angiotensin‐converting enzyme inhibitor–induced angioedema (AIIA). ## Study Design: Prospective cohort observational study. ## Methods: Over 1 year, 40 patients with AIIA were eva

Synthesis of the angiotensin converting
Synthesis of the angiotensin converting enzyme inhibitor 3H-RAC-X-65
✍ A. Y. K. Chung; J. W. Ryan; W. E. Groves; F. A. Valido; P. Berryer 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 349 KB

## Abstract We prepared the angiotensin converting enzyme (ACE) inhibitor N‐[1(S)‐carboxy‐3‐(4′‐^3^H)carboxanilidopropyl]‐L‐Ala‐L‐Pro (^3^H‐RAC‐X‐65). The triflate of D‐(+)‐lactic acid benzyl ester was reacted with N′‐(4‐iodophenyl)‐L‐glutamine methyl ester. The benzyl ester was removed with HF, an